Usual Adult Dose for Uveitis

4 mg (100 microliters of 40 mg/mL suspension) with subsequent dosage as needed over the course of treatment

Comments:

• Strict aseptic technique is mandatory.
• The vial should be vigorously shaken for 10 seconds before use.
• Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
• After withdrawal, the suspension should be injected without delay.
• Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.

• Treatment of sympathetic ophthalmia
• Treatment of temporal arteritis
• Treatment of uveitis
• Treatment of ocular inflammatory conditions unresponsive to topical

Usual Adult Dose for Temporal Arteritis

4 mg (100 microliters of 40 mg/mL suspension) with subsequent dosage as needed over the course of treatment

Comments:

• Strict aseptic technique is mandatory.
• The vial should be vigorously shaken for 10 seconds before use.
• Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
• After withdrawal, the suspension should be injected without delay.
• Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.

• Treatment of sympathetic ophthalmia
• Treatment of temporal arteritis
• Treatment of uveitis
• Treatment of ocular inflammatory conditions unresponsive to topical

Usual Adult Dose for Vitrectomy

1 to 4 mg (25 to 100 microliters of 40 mg/mL suspension) administered intravitreally

Comments:

• Strict aseptic technique is mandatory.
• The vial should be vigorously shaken for 10 seconds before use.
• Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
• After withdrawal, the suspension should be injected without delay.
• Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.

Usual Pediatric Dose for Uveitis

4 mg (100 microliters of 40 mg/mL suspension) with subsequent dosage as needed over the course of treatment

Comments:

• Strict aseptic technique is mandatory.
• The vial should be vigorously shaken for 10 seconds before use.
• Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
• After withdrawal, the suspension should be injected without delay.
• Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.

• Treatment of sympathetic ophthalmia
• Treatment of temporal arteritis
• Treatment of uveitis
• Treatment of ocular inflammatory conditions unresponsive to topical

Usual Pediatric Dose for Temporal Arteritis

4 mg (100 microliters of 40 mg/mL suspension) with subsequent dosage as needed over the course of treatment

Comments:

• Strict aseptic technique is mandatory.
• The vial should be vigorously shaken for 10 seconds before use.
• Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
• After withdrawal, the suspension should be injected without delay.
• Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.

• Treatment of sympathetic ophthalmia
• Treatment of temporal arteritis
• Treatment of uveitis
• Treatment of ocular inflammatory conditions unresponsive to topical

Usual Pediatric Dose for Vitrectomy

1 to 4 mg (25 to 100 microliters of 40 mg/mL suspension) administered intravitreally

Comments:

• Strict aseptic technique is mandatory.
• The vial should be vigorously shaken for 10 seconds before use.
• Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
• After withdrawal, the suspension should be injected without delay.
• Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.

Renal Dose Adjustments

Renal insufficiency: Use with caution

Liver Dose Adjustments

Data not available

Precautions

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

• The manufacturer product information should be consulted.

• Do not freeze.
• Protect from light.